The Swiss-based private equity group is among a group of international investors in Arsenal Capital Partners' debut $300m mid-market buyout fund.
The UK private equity firm has provided portfolio company Just Learning with funds to acquire Scotland-based CareShare.
Schroder Ventures Life Sciences, which closed $2m above its original target, received commitments from 18 institutions that backed the firm for the first time.
The US-based emerging markets private equity specialist has brought Denis Jungerman to assist with the roll-out of its Brazilian mezzanine operation.
Nineteen Finnish institutions have committed to the fund, which will invest in management buyouts across the Nordic region.
The firm has held a final close of its debut fund on E700m and has announced a cast of VIP appointments to its advisory board.
The US-based real estate group has closed its latest real estate fund on $335m, with a third of the fund's capital already invested.
Sofiposte, a subsidiary of the French state postal network, has raised E50m to invest in post, financial services and express courier businesses.
Vivendi Universal has chosen US venture capital firm Global Asset Capital to take over its struggling Viventures unit.
The US life sciences investor has sold the hepatitis and HIV treatment company to Novartis in a deal that values the business at up to $612m.
The UK bank will retain a near-20 per cent stake in Montagu Private Equity, which will remain the bank’s primary vehicle for European private equity investment.
CDC Ixis leads E10m photonics round; VC Strathdon raises further £2m; Cazenove backs Empower Interactive; European VCs complete Kaidara E8m round
Carlyle, Bain Capital and Texas Pacific have reportedly joined forces to back oil billionaire Marvin Davis in his pursuit of Vivendi’s US media assets.
Kurt Björklund is to head up Permira’s new presence in the Nordic region, working alongside the newly appointed Ole Oftedal, who joins as an industrial partner.
Texas-based Sevin Rosen Funds has become the latest US venture capital firm to cut its fund back, from $875m to $600m.